Apolipoprotein E (apo E) plays an important role in receptor mediated clearance of lipoprotein particles from plasma. Common genetic variation in apo E exists with three alleles coding for proteins called E2, E3, and E4. In in vitro receptor binding assays, E2 binds poorly, whereas E3 and E4 function normally. Recently, the apo E phenotype has been shown to have an effect on low density lipoprotein (LDL) cholesterol levels with levels in subjects with E2 lower and E4 higher than E3. We have examined the effect of the apo E polymorphism on dietary fat clearance using the vitamin A-fat loading test, which specifically labels intestinally derived lipoproteins with retinyl palmitate (RP). 27 normal subjects were studied, 10 with E3/3, 9 with E3/2, 7 with E4/3, and 1 with E4/4. After a vitamin A-containing fatty meal, postprandial RP concentrations were measured in chylomicron (Sf > 1,000) and nonchylomicron (Sf < 1,000) fractions for 14 h. Compared with E3/3 subjects, E3/2 subjects had a significantly higher nonchylomicron RP concentration (P < 0.05) (peak heights and areas below the curves) indicating slower clearance and the E4/3, E4/4 group had a significantly lower nonchylomicron RP concentration (P < 0.05) indicating faster clearance. The clearance in the latter group was twice that of E3/2 subjects (P < 0.01). Thus, heterozygosity for the defective form of apo E, E2, delays, and the surprising presence of a functionally normal allele, E4, increases clearance. This apo E effect on exogenous fat clearance may explain the recently described effect of the apo E phenotypes on LDL cholesterol levels.
Introduction
Apolipoprotein (apo) E is a constituent of plasma very low density lipoproteins (VLDL), intermediate density lipoproteins (IDL), high density lipoproteins (HDL) , and chylomicron remnants (1) (2) (3) . It is recognized by LDL receptors and hepatic chylomicron remnant receptors and mediates hepatic uptake of IDL and chylomicron remnants, and in this manner, plays an important role in lipoprotein metabolism (4) (5) (6) (7) (8) . Different forms of apo E have been recognized in humans due to genetic variation in the apo E gene resulting from three common alleles in the population, E4, E3 and E2, with frequencies Type III hyperlipoproteinemia, a disorder characterized by increased cholesterol and triglyceride levels (due to the presence of chylomicron remnants in fasting plasma), premature coronary and peripheral vascular disease, and tuberoeruptive and palmar xanthomas is strongly associated with the E2/2 phenotype present in 1% of the population (10, 17, 18) . E2 binds poorly to receptors and this is thought to account for the defective chylomicron remnant clearance in this disorder (19, 20) . The influence ofthe other apo E phenotypes on dietary fat clearance has not been studied.
Recently, population based studies have shown that the apo E polymorphism is associated with differences in plasma LDL levels. Phenotypes E4/4 and E4/3 are associated with higher and E3/2 and E2/2 with lower LDL cholesterol levels than E3/3 (12, 13, (21) (22) (23) (24) . The association of elevated LDL cholesterol levels with coronary heart disease susceptibility is well documented (25, 26) and heightens the importance of understanding the influence of the apo E phenotype on LDL levels. Apo E is not a constituent of LDL and its influence must be indirect.
In the current study, we used the vitamin A-fat loading test, which specifically labels intestinally derived lipoproteins with retinyl palmitate (27) (28) (29) (30) (31) (32) (33) (34) , to follow the metabolism of exogenous fat to see if the apo E phenotype affects dietary fat clearance. We show that the common apo E phenotypes do affect dietary fat clearance and we then present a model whereby this may explain the effect of the apo E phenotype on LDL cholesterol levels.
Methods
Subjects. 27 It contained 600 mg cholesterol/ 1,000 calories, and the P/S ratio was 0.3. This was given as a milkshake, scrambled eggs, bread and cheese, and was eaten in 10 min. The vitamin A was added to the milkshake. After the meal, subjects stayed fasting for 14 h, but as much drinking water was allowed as desired. To measure levels of retinyl palmitate, blood samples were drawn before the meal and every hour after the meal until 6 h, then every 2 h until 14 h. The subjects tolerated the meal well, and no one had diarrhea or other symptoms of malabsorption. Analysis of samples. Venous blood was drawn from the forearm and transferred to a tube containing sodium EDTA. Samples were immediately centrifuged at 1,500 g for 15 min and 0.5 ml of plasma was stored wrapped in foil at -200C for retinyl ester assay. Another 0.5 ml was stored at 4VC for triglyceride determinations. An aliquot of 2.5 ml ofplasma was transferred into a 1/2 X 2 in. cellulose nitrate tube and overlayered with 2.5 ml sodium chloride solution (d = 1.006 g/ml). Tubes were subjected to preparative ultracentrifugation for 1.6 X 106 g-min in a rotor (SW-55; Beckman Instruments, Inc., Fullerton, CA) to float chylomicron particles of Sf > 1,000 (35) (36) (37) . The chylomicroncontaining supernatant was removed and brought to a total volume of 2 ml with saline. The infranatant was brought to a volume of 5 ml with saline. 0.5-ml aliquots ofsupernatant and infranatant were wrapped in foil and assayed for retinyl ester. Additional aliquots were assayed for triglyceride concentration. As discussed elsewhere, the procedure appears to separate a predominantly chylomicron population from a predominantly remnant population (34, 35 pellet was washed twice with cold ether, and dissolved in 0.2 to 0.3 ml of a buffer containing 6 M urea, 0.01 M Tris HCl, 0.01 M dithiothreitol, pH 8.6. Protein concentration was determined by a Bio-Rad assay using bovine serum albumin as a reference. A one-dimensional isoelectric focusing gel was prepared in a 6-M urea buffer containing 7.5% acrylamide, 0.2% NN'-methylene-bis-acrylamide (BIS) and 2% ampholines of pH 4-6.5. The gel was prefocused for I h at 4VC at 1 10 V, and then 50Mg ofVLDL protein was applied to each gel lane. Focusing was carried out for 17 h at 4VC at 250 V. After focusing, the gels were fixed in trichloroacetic acid-sulfosalicylic acid, stained with Coomassie Blue (0.1%) in methanol, water, acetic (4.5:4.5:1.0), and destained. Specimens from individuals with known apo E phenotypes were run along with new samples to aid in the interpretation of the results.
Postheparin plasma lipolytic activities. Lipolytic activities were determined 1 wk before the vitamin A-fat loading test. Lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL) were released into the circulation by intravenous heparin injection at a dose of60 U/kg body wt. After 15 min blood was drawn into tubes containing 4 mM EDTA. The plasma was immediately separated at 4VC by centrifugation at 2,700 rpm for 12 min and promptly frozen at -70'C. The assay itselfis a modification ofthe method of Krauss (41) as recently described (34) . In short, 20 Ml of postheparin plasma is added to freshly sonified substrate, containing radiolabeled and unlabeled triolein and triton in a Tris HC1 buffer pH 8.6, mixed, and incubated for 20 min at 37°C. The reaction is stopped by a mixture of chloroform, methanol, and heptane, and a base in the form of K2CO3 is added. After mixing and centrifugation, an aliquot ofthe aqueous phase is counted and the total lipolytic activity is given as micromoles FFA liberated/milliliter plasma/hour. Another aliquot of 20 Ml of postheparin plasma is incubated for I h at 4°C with 25 Ml of rabbit anti-human LPL antiserum before the lipase assay described above. The antiserum was prepared in our laboratory by injecting rabbits with LPL purified from fresh human breast milk. This antiserum completely inhibited the activity of purified human breast milk lipoprotein lipase, but had no effect on human hepatic lipase purified by heparin Sepharose chromatography from postheparin plasma. LPL activity is the difference between total and antiserum-inhibited activity. The latter is taken to be the HTGL activity.
Statistical analysis. The differences between groups of subjects were analyzed for significance mainly using unpaired Student t tests. Differences in dietary fat clearance between the apo E phenotype groups were also sought using analysis ofvariance, and Duncan's multiple comparison tests. Calculations were performed on The Rockefeller University Hospital CLINFO system.
Results
Subject characteristics. The clinical features, lipid levels, and plasma postheparin lipolytic activities for groups of subjects are presented in Table I . When males and females are compared, males had lower HDL cholesterol levels (P = 0.003) and a trend towards lower LPL and higher HTGL activities, P = 0.11 and P = 0.054, respectively. The subjects were also grouped by age as older (40-72 yr) and younger (19-28 yr) . Older subjects had lower LPL (P = 0.0 19) and higher HTGL (P = 0.032) activities when compared with younger subjects. Apo E phenotype analysis revealed 9 subjects with E3/2, 10 with E3/3, 7 with E4/3, and 1 with E4/4. There were no subjects with E4/2 or E2/2. For purposes of analysis, the results from the person with E4/4 were combined with those for the E4/3 group. This did not substantially affect any of the results. E3/2 individuals had lower LDL cholesterol levels than E3/3 subjects (P = 0.003), whereas those in the E4/3, E4/4 grouping showed a trend to higher LDL cholesterol levels than E3/3 individuals, but this was not significant (P = 0.1 16). The apo E Effects of age and sex on dietary fat clearance. Plasma chylomicron and nonchylomicron RP concentrations during the vitamin A-fat loading test for the different groups are shown in Fig. 1 . Table II represents the means and SD of the peak RP response and area below the curves. There was no significant effect of sex, but males showed a tendency to a higher chylomicron RP response. Age affected chylomicron RP response with older subjects having 33% higher RP peak values and 50% higher RP area (P < 0.05). There was no effect of age on the magnitude of the nonchylomicron RP response. The peak level of chylomicron and nonchylomicron RP was slightly delayed in older subjects. From the shape ofthe curves, this was possibly due to diminished chylomicron RP clearance, which is compatible with the lower LPL activity measured in older subjects.
Effects ofthe apo Ephenotype on dietaryfat clearance. The chylomicron and nonchylomicron RP response to the vitamin A-fat loading test in subjects with different apo E phenotypes are shown in Fig. 1 and Table II . In contrast to the age effects, the apo E phenotype had no effect on the chylomicron RP response, but had a significant effect on the nonchylomicron fraction. In both peak height and area below the curve, the nonchylomicron RP fraction was highest in E3/2 subjects, intermediate in E3/3 subjects, and lowest in the E4/3, E4/4 group. The values for E3/3 subjects were significantly different from each ofthe other two groups (P < 0.05). The E3/2 values were over twofold greater than the E4/3, E4/4 subjects (P < 0.01). Analysis of variance also showed that the three apo E phenotype groups differed significantly (P = 0.0015). Duncan's multiple comparison test revealed significant differences between any two of the groups (P < 0.05). Fig. 2 presents the data for total plasma, chylomicron, and nonchylomicron RP peak heights during the vitamin A-fat loading test in individual subjects. For the nonchylomicron RP response, a comparison ofsubjects with the E3/2 and E4/3, E4/4 phenotypes shows almost no overlap. Furthermore, none ofthe E4/3, E4/4 subjects had a response higher than the mean for the E3/3 group, and only one subject with E3/2 had a response lower than the E3/3 mean.
During the vitamin A-fat loading test total plasma, chylomicron, and nonchylomicron triglyceride responses were analyzed (data not shown). Older subjects showed a significantly higher chylomicron triglyceride response (P < 0.05). However, there were no differences in the nonchylomicron responses between the apo E phenotypes, as seen in the vitamin A-fat loading test. This reflects the fact that triglyceride levels are not a sensitive or specific way to determine nonchylomicron response to a fatty meal, because of the presence of a large pool of triglyceride-rich lipoproteins of endogenous origin in the Sf < 1,000 plasma fraction (34) .
To assess whether diet might affect the results observed, the 16 subjects studied as inpatients on the 42% fat diet were restudied with the same fatty meal after 3 wk on an American Heart Association Phase II diet (caloric distribution: fat 25%, protein 15%, carbohydrate 60%, with a P/S ratio of 1.3 and a cholesterol intake of 85 mg/l ,000 cal). For individual subjects, no differences were found between the diets (data not shown). Thus age, sex, and diet variables could not confound the ohservation of an apo E phenotype effect on the clearance of the nonchylomicron fraction. 
Discussion
The aim of the present investigation was to determine the effect of the common apo E protein polymorphism on the metabolism of dietary fats. The basis for this polymorphism is variation in the apo E gene (9-11). The most common allele gene product, E3, is a 299 amino acid polypeptide (42) , whose receptor binding region resides between residues 140 and 160 (43) (44) (45) . E3 contains a single cysteine at residue 112. The two common polymorphic forms of apo E differ from E3 at a single amino acid residue. E2 contains a cysteine for arginine substitution at residue 158 and has < 1% of normal receptor binding capacity in in vitro assays (19, 20) . E4 contains an arginine for cysteine substitution at residue 1 12 and has normal in vitro receptor binding capacity (19) . (10, 17, 18) . This is not surprising since chylomicron remnants depend on apo E for recognition and clearance by the liver chylomicron remnant receptor. Although the E2/2 phenotype is present in 1% of the population, < 5% of people with E2/2 have overt type III hyperlipoproteinemia and disease expression is related to age, diet, adiposity, hormonal status, and probably the presence of other hyperlipidemia genes (46, 47) . Even in normolipidemic E2/2 subjects, elevated levels of chylomicron remnants have been described implying decreased clearance (22, 33, 48) .
We have previously shown that the vitamin A-fat loading test, as applied in our laboratory, is an adequate tool to follow the metabolism of large and small postprandial fat particles, which we believe correspond principally to chylomicron and chylomicron remnants, respectively. The large particles (Sf > 1,000) called the chylomicron fraction in normal people are cleared in proportion to HDL levels and postheparin lipoprotein lipase activity. In addition, their clearance is delayed in type IV patients with improvement documented after gemfibrozil therapy. The small particles (Sf < 1,000) called the nonchylomicron fraction in normal people are cleared in proportion to postheparin hepatic triglyceride lipase levels and show delayed clearance in type III hyperlipoproteinemic patients (34) . In the current study, we show that individuals with the E3/2 phenotype have delayed postprandial clearance of the small particles, the nonchylomicron fraction that behaves like chylomicron remnants. This is similar, but in a milder form, to what is seen in E2/2 individuals and documents a metabolic defect in postprandial fat metabolism in carriers of the defective allele, E2, who comprise -15% ofthe general population.
A very surprising result of the current study was that individuals with the E4/3 phenotype, who comprise 23% of the general population, actually had accelerated postprandial clearance of the nonchylomicron fraction. This suggests that they clear chylomicron remnants into the liver more rapidly than E3/3 individuals and strikingly twice as fast as E3/2 individuals. E4 behaves normally in receptor binding assays (19) compatible with its amino acid substitution being outside of the receptor binding region. Therefore, another explanation is required to explain its anomalous behavior compared to E3. One hypothesis is the following (Fig. 3) Figure 3 . Schematic diagram of a possible mechanism by which the common apo E phenotypes affect chylomicron remnant uptake by liver and LDL cholesterol levels in plasma.
has been observed that most plasma apo E resides in HDL and after fat ingestion apo E shifts from HDL to postprandial particles (49) (50) (51) . Since E4 contains no cysteine, where E3 contains one residue of cysteine, it can be conjectured that E4 in HDL cannot form disulfide bonds with other proteins and shifts more rapidly than E3 to chylomicron remnants. Disulfide bonding of apo E to apo A-II in HDL has been demonstrated (52) . In this manner individuals with E4 might more efficiently and rapidly deliver dietary fat to the liver. A recent study injecting radiolabeled E4 and E3 showed that E4 was cleared more rapidly than E3 from plasma and that E3 preferentially associated with HDL (53). These observations are compatible with the hypothesis. Very recently, it has become apparent that the common apo E phenotypes profoundly affect LDL cholesterol levels in the general population. In comparison to E3/3 individuals (56% of population), E3/2 individuals have lower and E4/3 individuals have higher LDL cholesterol levels (12, 13, (21) (22) (23) (24) . The LDL levels in the current study show the same trend and the difference seen between the phenotypes in the metabolic behavior of postprandial particles suggest a mechanism for the LDL observations (Fig. 3) . The liver is the main site ofremoval of plasma LDL. It is a dynamic organ with several constantly active, regulated mechanisms affecting its cholesterol and fatty acid pools. Therefore, the rate of exogenous fat removal by the liver could influence the liver's rate of removal of endogenous fat containing particles. One mechanism could be by LDL receptor regulation. Thus, the slower hepatic clearance of dietary fat in E3/2 subjects could result in up regulation of LDL receptors, and a decrease in plasma LDL levels. The faster hepatic clearance of dietary fat in E4/3 subjects could cause the opposite, down regulation of LDL receptors, and an increase in plasma LDL levels. A recent analysis estimated that 16% of the genetic variation in LDL cholesterol levels in the general population could be accounted for by the three structural alleles at the apo E gene locus (54) . The data presented in the current report could explain the mechanism of this relationship.
